Delivery Order SPE2DB20D1100-SPE2DB25FE6R7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,498.10 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's broader federal medical supply portfolio and reflects...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors, valued at $3,093.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999...
- The Defense Logistics Agency awarded a $2,167.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on May 14, 2025, with completion targeted for May 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical and medical supply relationship with DLA. The sensors will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal healthcare procurement needs. This award...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive federal medical supply relationship with DLA, leveraging the company's established...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,845.71. This firm fixed-price contract, executed on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award...
- The Defense Logistics Agency awarded a $1,051.18 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexcom G7 sensors, continuous glucose monitoring devices used for diabetes management. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026. The...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6R7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,456.25 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with a completion date of September 16, 2025. The award represents a continuation of AmerisourceBergen's role as a critical supplier of medical devices and pharmaceutical products to the Department of Defense and related federal healthcare systems. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical devices—including specialty medications, vaccines, and diagnostics—to support military healthcare programs globally. The DLA Troop Support Medical supply chain leverages such contracts to efficiently provision the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities with essential medical commodities, with Dexcom G7 sensors supporting diabetes management across military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/15/25 |